0001362118-23-000034.txt : 20230530 0001362118-23-000034.hdr.sgml : 20230530 20230530153001 ACCESSION NUMBER: 0001362118-23-000034 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230526 FILED AS OF DATE: 20230530 DATE AS OF CHANGE: 20230530 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Roberts Brad Michael CENTRAL INDEX KEY: 0001844066 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39785 FILM NUMBER: 23975813 MAIL ADDRESS: STREET 1: 300 CHAFFORD COURT CITY: SIMPSONVILLE STATE: SC ZIP: 29681 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LifeMD, Inc. CENTRAL INDEX KEY: 0000948320 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] IRS NUMBER: 760238453 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 236 FIFTH AVENUE STREET 2: SUITE 400 CITY: NEW YORK STATE: NY ZIP: 10001 BUSINESS PHONE: (866) 351-5907 MAIL ADDRESS: STREET 1: 236 FIFTH AVENUE STREET 2: SUITE 400 CITY: NEW YORK STATE: NY ZIP: 10001 FORMER COMPANY: FORMER CONFORMED NAME: CONVERSION LABS, INC. DATE OF NAME CHANGE: 20180622 FORMER COMPANY: FORMER CONFORMED NAME: Immudyne, Inc. DATE OF NAME CHANGE: 20120514 FORMER COMPANY: FORMER CONFORMED NAME: IMMUDYNE INC DATE OF NAME CHANGE: 19950720 4 1 primary_doc.xml PRIMARY DOCUMENT X0407 4 2023-05-26 0 0000948320 LifeMD, Inc. LFMD 0001844066 Roberts Brad Michael C/O LIFEMD, INC. 236 FIFTH AVENUE, 4TH FLOOR NEW YORK NY 10001 0 1 0 0 Chief Operating Officer 0 Common Stock, par value $0.01 2023-05-26 4 P 0 30000 2.1902 A 97632 D The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.1798 to $2.20 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. /s/ Brad Michael Roberts 2023-05-30